AMD’s $35bn deal to buy Xilinx has been delayed into 2022 by the regulator in China. The deal has approval from US and European regulators, but Chinese approval relied on changes to the structure of the deal with ‘market remedies’.
“We continue making good progress on the required regulatory approvals to close our transaction,” said AMD. ”While we had previously expected that we would secure all approvals by the end of 2021, we have not yet completed the process and we now expect the transaction to close in the first quarter of 2022. Our conversations with regulators continue to progress productively, and we expect to secure all required approvals.”
The progression of the deal is in sharper focus in the light of tension between the US and Chinese governments over trade. Nvidia’s deal to buy UK processor developer ARM, initially valued at $40bn and now potentially worth $54bn, has also fallen foul of regulators in the US, Europe and China.
- Opinion: Data centre AI drives $30bn AMD-Xilinx deal
- Xilinx follows security collaboration with investment
- Xilinx enters System-on-Module business with ‘open’ standard
Other articles on eenews Europe